SYNTHESIS OF SILVER, ANTIMONY, AND TIN DOPED BISMUTH TELLURIDE NANOPARTICLES AND BULK BISMUTH TELLURIDE TO FORM BISMUTH TELLURIDE COMPOSITES
    1.
    发明申请
    SYNTHESIS OF SILVER, ANTIMONY, AND TIN DOPED BISMUTH TELLURIDE NANOPARTICLES AND BULK BISMUTH TELLURIDE TO FORM BISMUTH TELLURIDE COMPOSITES 有权
    合成银,抗氧化剂和钛掺杂的二氧化钛纳米颗粒和块状双螺旋体,形成双螺旋三聚体复合材料

    公开(公告)号:US20120145212A1

    公开(公告)日:2012-06-14

    申请号:US13398274

    申请日:2012-02-16

    摘要: According to various aspects, exemplary embodiments are provided of thermoelectric materials, which embodiments may have improved figure of merit. In one exemplary embodiment, a thermoelectric material generally includes bismuth telluride nanoparticles, which may be undoped or doped with at least one or more of silver, antimony, tin, and/or a combination thereof. The bismuth telluride nanoparticles may be dispersed in a matrix material comprising particulate bismuth telluride. Methods for making undoped and doped bismuth telluride nanoparticles are also disclosed, which may include a solvothermal method for making bismuth telluride nanoparticles having a size ranging from 1 to 200 nanometers.

    摘要翻译: 根据各个方面,提供了热电材料的示例性实施例,这些实施例可以具有改进的品质因数。 在一个示例性实施例中,热电材料通常包括碲化铋纳米颗粒,其可以是未掺杂的或掺杂有银,锑,锡和/或其组合中的至少一种或多种。 碲化铋纳米颗粒可以分散在包含颗粒状碲化铋的基质材料中。 还公开了制备未掺杂和掺杂的碲化铋纳米颗粒的方法,其可以包括制备尺寸范围为1至200纳米的碲化铋纳米颗粒的溶剂热方法。

    Preparation of dihydropyridines
    3.
    发明授权
    Preparation of dihydropyridines 有权
    二氢吡啶的制备

    公开(公告)号:US08455655B2

    公开(公告)日:2013-06-04

    申请号:US13102101

    申请日:2011-05-06

    IPC分类号: C07D213/803

    摘要: The invention relates to a method and compounds for the preparation of clevidipine butyrate, a very short acting hypertensive calcium antagonist, as well as the synthesis of these compounds useful for the preparation of clevidipine (also known as clevidipine butyrate). Moreover the invention also discloses polymorphic forms of clevidipine butyrate, useful for the preparation of pharmaceutical compositions, and processes to prepare them.

    摘要翻译: 本发明涉及制备丁酸氯维地平(一种非常短暂的高血压钙拮抗剂)的方法和化合物,以及这些化合物的合成,这些化合物可用于制备氯维地平(也称为丁酸吡啶地平)。 此外,本发明还公开了可用于制备药物组合物的丁酸氯维地平的多晶型物及其制备方法。

    Synthesis of silver, antimony, and tin doped bismuth telluride nanoparticles and bulk bismuth telluride to form bismuth telluride composites
    5.
    发明授权
    Synthesis of silver, antimony, and tin doped bismuth telluride nanoparticles and bulk bismuth telluride to form bismuth telluride composites 有权
    合成银,锑和锡掺杂的碲化铋纳米颗粒和大量碲化铋以形成碲化铋复合材料

    公开(公告)号:US08748726B2

    公开(公告)日:2014-06-10

    申请号:US13398274

    申请日:2012-02-16

    摘要: According to various aspects, exemplary embodiments are provided of thermoelectric materials, which embodiments may have improved figure of merit. In one exemplary embodiment, a thermoelectric material generally includes bismuth telluride nanoparticles, which may be undoped or doped with at least one or more of silver, antimony, tin, and/or a combination thereof. The bismuth telluride nanoparticles may be dispersed in a matrix material comprising particulate bismuth telluride. Methods for making undoped and doped bismuth telluride nanoparticles are also disclosed, which may include a solvothermal method for making bismuth telluride nanoparticles having a size ranging from 1 to 200 nanometers.

    摘要翻译: 根据各个方面,提供了热电材料的示例性实施例,这些实施例可以具有改进的品质因数。 在一个示例性实施例中,热电材料通常包括碲化铋纳米颗粒,其可以是未掺杂的或掺杂有银,锑,锡和/或其组合中的至少一种或多种。 碲化铋纳米颗粒可以分散在包含颗粒状碲化铋的基质材料中。 还公开了制备未掺杂和掺杂的碲化铋纳米颗粒的方法,其可以包括制备尺寸范围为1至200纳米的碲化铋纳米颗粒的溶剂热方法。

    Novel Process for Preparation of Bicalutamide
    7.
    发明申请
    Novel Process for Preparation of Bicalutamide 审中-公开
    制备比卡鲁胺的新方法

    公开(公告)号:US20080177109A1

    公开(公告)日:2008-07-24

    申请号:US11574886

    申请日:2005-05-10

    IPC分类号: C07C315/02

    摘要: The present invention discloses a process for the synthesis of N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulphonyl]-2-hydroxy-2-methyl propanamide (Form I). The invention discloses a reagent for oxidation of N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methyl propanamide to N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulphonyl]-2-hydroxy-2-methyl propanamide. More particularly, the invention discloses a method of purification of N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulphonyl]-2-hydroxy-2-methyl propanamide in a mixture of methylethyl ketone and hexane giving form (I). This form (I) is useful as an active pharmaceutical and has antiandrogenic activity.

    摘要翻译: 本发明公开了N- [4-氰基-3-(三氟甲基)苯基] -3 - [(4-氟苯基)磺酰基] -2-羟基-2-甲基丙酰胺(形式I)的合成方法。 本发明公开了一种用于将N- [4-氰基-3-(三氟甲基)苯基] -3 - [(4-氟苯基)硫] -2-羟基-2-甲基丙酰胺氧化成N- [4-氰基 - 3-(三氟甲基)苯基] -3 - [(4-氟苯基)磺酰基] -2-羟基-2-甲基丙酰胺。 更具体地说,本发明公开了一种将N- [4-氰基-3-(三氟甲基)苯基] -3 - [(4-氟苯基)磺酰基] -2-羟基-2-甲基丙酰胺在甲基乙基 酮和己烷,得到形式(I)。 该形式(I)可用作活性药物并具有抗雄激素活性。